- Preview Available
- Scholarly Journal
Neo-adjuvant pembrolizumab in stage IV high-grade serous ovarian cancer: the phase II Neo-Pembro trial
Nature Communications; London Vol. 16, Iss. 1, (2025): 3520.
DOI:10.1038/s41467-025-58440-y
This is a limited preview of the full PDF
Try and log in through your library or institution to see if they have access.